Arterial	arterial	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
as	as	O	O	O	O
a	a	O	O	O	O
complication	complication	O	O	O	O
of	of	O	O	O	O
prolonged	prolonged	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
of	of	O	O	O	O
14	14	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
Cushing	cushing	O	O	OTHERS	I
's	's	O	O	OTHERS	I
syndrome	syndrome	O	O	OTHERS	I
treated	treated	O	O	O	O
on	on	O	O	O	O
a	a	O	O	O	O
long-term	long-term	O	O	O	O
basis	basis	O	O	O	O
with	with	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
developed	developed	O	O	O	O
sustained	sustained	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
both	both	O	O	O	O
cases	cases	O	O	O	O
normal	normal	O	O	O	O
plasma	plasma	O	O	O	O
and	and	O	O	O	O
urinary	urinary	O	O	O	O
free	free	O	O	O	O
cortisol	cortisol	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
achieved	achieved	O	O	O	O
following	following	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
,	,	O	O	O	O
yet	yet	O	O	O	O
continuous	continuous	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
monitoring	monitoring	O	O	O	O
demonstrated	demonstrated	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
31	31	O	O	O	O
(	(	O	O	O	O
patient	patient	O	O	O	O
1	1	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
52	52	O	O	O	O
weeks	weeks	O	O	O	O
(	(	O	O	O	O
patient	patient	O	O	O	O
2	2	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
treatment	treatment	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
patient	patient	O	O	O	O
1	1	O	O	O	O
,	,	O	O	O	O
plasma	plasma	O	O	O	O
levels	levels	O	O	O	O
of	of	O	O	O	O
deoxycorticosterone	deoxycorticosterone	O	O	OTHERS	I
and	and	O	O	O	O
11-deoxycortisol	11-deoxycortisol	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
elevated	elevated	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
patient	patient	O	O	O	O
2	2	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
addition	addition	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
deoxycorticosterone	deoxycorticosterone	O	O	OTHERS	I
and	and	O	O	O	O
11-deoxycortisol	11-deoxycortisol	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
,	,	O	O	O	O
plasma	plasma	O	O	O	O
aldosterone	aldosterone	CHEMICALS	O	OTHERS	I
values	values	O	O	O	O
were	were	O	O	O	O
raised	raised	O	O	O	O
,	,	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
concomitant	concomitant	O	O	O	O
suppression	suppression	O	O	O	O
of	of	O	O	O	O
renin	renin	O	O	O	O
levels	levels	O	O	O	O
.	.	O	O	O	O

Our	our	O	O	O	O
findings	findings	O	O	O	O
show	show	O	O	O	O
that	that	O	O	O	O
long-term	long-term	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
ketoconazole	ketoconazole	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
induce	induce	O	O	O	O
enzyme	enzyme	O	O	O	O
blockade	blockade	O	O	O	O
leading	leading	O	O	O	O
to	to	O	O	O	O
mineralocorticoid-related	mineralocorticoid-related	O	O	O	O
hypertension	hypertension	O	DISEASE	OTHERS	I
.	.	O	O	O	O

